Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age30-50
SponsorKrishnadevaraya College of Dental Sciences & Hospital

About this trial

The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis

Eligibility criteria

Qualifiers

Patient with have chronic periodontitis in the age group between 30-50 years.

Patients having ≥20 teeth.

Patients who are systematically healthy.

Patients with localized pockets with probing depth of ≤ 5mm.

Disqualifiers

Patients who have received any surgical or nonsurgical therapy during past 6months

Pregnant or lactating females.

Use of systemic antibiotics in the past 6 months.

Patient who are not willing to give a written informed consent

Trial design

Treatments tested in this trial

  • Bromelain gel
  • chlorhexidine gel
  • SRP

Treatment groups

36 Participants
are divided into 3 treatment groups